Japan Nuclear Medicine Market Size, Share, and COVID-19 Impact Analysis, By Product (Diagnostics and Therapeutics), By Application (Cardiology, Neurology, Urology, Oncology, and Other), and Japan Nuclear Medicine Market Insights, Industry Trend, Forecasts to 2035.

Japan Nuclear Medicine Market Insights Forecasts to 2035

• The Japan Nuclear Medicine Market Size Was Estimated at USD 641.7 Million in 2024
• The Market Size is Expected to Grow at a CAGR of Around 10.37% from 2025 to 2035
• The Japan Nuclear Medicine Market Size is Expected to Reach USD 1899.1 Million by 2035

According to a research report published by Spherical Insights & Consulting, the Japan Nuclear Medicine market is anticipated to reach USD 1899.1 million by 2035, growing at a CAGR of 10.37% from 2025 to 2035. The Japanese nuclear medicine market is driven by various factors, including rising prevalence of cardiovascular diseases and cancer, advancements in radioisotopes technology, rising aging population, and government support.

Market Overview

Nuclear medicine is a specialized branch of medical imaging and treatment that diagnoses and treats illnesses by using small amounts of radioactive materials called radiopharmaceuticals. These medicines are used to treat conditions like cancer, cardiovascular diseases, and neurological disorders. Japan has one of the largest populations, and aging population is more susceptible to cardiovascular diseases, which is a key driver for nuclear medicine market. Rise in cancer cases due to unhealthy lifestyles is driving the need for precise diagnostic tools and targeted radiopharmaceutical treatments. The rising demand for personalized medicines is a key trend in this market. The Japanese nuclear medicine market provides good opportunities with the increasing use of theranostics and neurological imaging, particularly for age-related diseases.

Report Coverage

This research report categorizes the market for the Japan nuclear medicine market based on various segments and regions, and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan nuclear medicine market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan nuclear medicine market.

Driving Factors

The Japan nuclear medicine market is experiencing strong growth due to several factors. Japan is one of the most rapidly aging countries in the world, with an increasing prevalence of chronic and age-related diseases such as cancer, cardiovascular disease, and neurological disorders. This creates the demand for sophisticated diagnostic and treatment tools such as PET and SPECT imaging. The growing health awareness regarding early disease detection and treatment is encouraging health providers to use nuclear medicine technology. Additionally, technological advancements play a crucial role in market growth.

Restraining Factors

The nuclear medicine technologies like PET and SPECT is expensive, which can be a major barrier for small clinics and hospitals. Additionally, there are strict regulations for the use of radioactive materials further limit the market expansion.

Market Segmentation

The Japan nuclear medicine market share is classified into product and application.

• The diagnostics segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan nuclear medicine market is segmented by product into diagnostics and therapeutics. Among these, the diagnostics segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to the presence of a large patient base and the availability of advanced technologies. Additionally, the rising prevalence of chronic diseases is contributing to drive the market.

• The urology segment held a significant share in 2024 and is expected to grow at a substantial CAGR during the forecast period.

The Japan nuclear medicine market is segmented by application into cardiology, neurology, urology, oncology, and other. Among these, the urology segment held a significant share in 2024 and is expected to grow at a substantial CAGR during the forecast period. This is due to the rising prevalence of urological disorders. Additionally, technological advancements play an important role in the growth of this segment.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Japan nuclear medicine market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• FUJIFILM Toyama Chemical Co., Ltd
• CANON MEDICAL SYSTEMS CORPORATION
• Nihon Medi-Physics Co., Ltd.
• ATOX Co., Ltd
• JFE Engineering Corporation
• GE Healthcare
• Mallinckrodt
• Cardinal Health
• Bracco Imaging
• Other

Recent Devlopments

• In October 2024, Curium announced a strategic partnership with PeptiDreams PDRadiopharma to co-devlop and commericalize 177 Lu-PSMA-landT and 64 Cu-PSMA-land T for prostate cancer in japan.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at Japan, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Japan nuclear medicine market based on the below-mentioned segments:

Japan Nuclear Medicine Market, By Product

• Diagnostics
• Therapeutics

Japan Nuclear Medicine Market, By Application

• Cardiology
• Neurology
• Urology
• Oncology
• Other